Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

11.35

+0.05 (0.44%)

At close: Mar 9, 2026, 4:00 PM EDT

11.39

+0.04 (0.35%)

After-hours: Mar 9, 2026, 5:26 PM EDT

Keros Therapeutics Market Cap

Keros Therapeutics has a market cap or net worth of $223.79 million as of March 9, 2026. Its market cap has decreased by -49.91% in one year.

Market Cap

223.79M

Enterprise Value

-46.74M

1-Year Change

-49.91%

Ranking

#3764

Market Cap Chart

Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $223.79M, a decrease of -41.92%. That is a compound annual growth rate of -8.78%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	222.81M	-64.08%
Dec 31, 2025	620.29M	-3.27%
Dec 31, 2024	641.23M	-46.17%
Dec 29, 2023	1.19B	-9.94%
Dec 30, 2022	1.32B	-3.39%
Dec 31, 2021	1.37B	-16.27%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cartesian Therapeutics	234.55M
Protalix BioTherapeutics	231.61M
Humacyte	231.60M
Eledon Pharmaceuticals	230.12M
Canton Strategic Holdings	229.26M
Voyager Therapeutics	228.52M
Editas Medicine	226.48M
MediWound	224.67M

Market Cap Rankings